Wells Fargo Adjusts NovoCure's Price Target to $49 From $102, Keeps Overweight Rating

USA
EnglishUK
EnglishIndia
EnglishAustralia
EnglishCanada
EnglishFrance
FrançaisSuisse
FrançaisEspaña
EspañolDeutschland
DeutschÖsterreich
DeutschSchweiz
DeutschBelgië
NederlandsNederland
NederlandsItalia
ItalianoSverige
Svenska
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.48 USD | +3.55% |
|
+1.03% | -24.56% |
Feb. 12 | C Worldwide Healthcare Select up 5.8% in January - divests Illumina | FW |
Jan. 22 | NovoCure Opens New Global Headquarters in Switzerland | MT |